Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Changes in invasive breast cancer and ductal carcinoma in situ rates in relation to the decline in hormone therapy use.

Farhat GN, Walker R, Buist DS, Onega T, Kerlikowske K.

J Clin Oncol. 2010 Dec 10;28(35):5140-6. doi: 10.1200/JCO.2010.29.5121. Epub 2010 Nov 8.

2.

Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.

Glass AG, Lacey JV Jr, Carreon JD, Hoover RN.

J Natl Cancer Inst. 2007 Aug 1;99(15):1152-61. Epub 2007 Jul 24.

PMID:
17652280
3.

Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study.

Román M, Rué M, Sala M, Ascunce N, Baré M, Baroja A, De la Vega M, Galcerán J, Natal C, Salas D, Sánchez-Jacob M, Zubizarreta R, Castells X; Cumulative False Positive Risk Group.

PLoS One. 2013 Dec 23;8(12):e83121. doi: 10.1371/journal.pone.0083121. eCollection 2013.

4.

Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.

Kerlikowske K, Miglioretti DL, Buist DS, Walker R, Carney PA; National Cancer Institute-Sponsored Breast Cancer Surveillance Consortium.

J Natl Cancer Inst. 2007 Sep 5;99(17):1335-9. Epub 2007 Aug 14. Erratum in: J Natl Cancer Inst. 2007 Oct 3;99(19):1493.

PMID:
17698950
5.

Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?

Erbas B, Amos A, Fletcher A, Kavanagh AM, Gertig DM.

Cancer Epidemiol Biomarkers Prev. 2004 Oct;13(10):1569-73.

6.

Digital Mammography Screening: Does Age Influence the Detection Rates of Low-, Intermediate-, and High-Grade Ductal Carcinoma in Situ?

Weigel S, Hense HW, Heidrich J, Berkemeyer S, Heindel W, Heidinger O.

Radiology. 2016 Mar;278(3):707-13. doi: 10.1148/radiol.2015150322. Epub 2015 Oct 27.

PMID:
26505802
7.

Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer.

Kerlikowske K, Barclay J, Grady D, Sickles EA, Ernster V.

J Natl Cancer Inst. 1997 Jan 1;89(1):76-82.

PMID:
8978410
8.

In situ breast cancer: incidence trend and organised screening programmes in Italy.

Barchielli A, Federico M, De Lisi V, Bucchi L, Ferretti S, Paci E, Ponti A, Buiatti E.

Eur J Cancer. 2005 May;41(7):1045-50.

PMID:
15862754
9.

Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma.

Ernster VL, Barclay J.

J Natl Cancer Inst Monogr. 1997;(22):151-6. Review.

PMID:
9709292
10.

Incidence of and treatment for ductal carcinoma in situ of the breast.

Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson C.

JAMA. 1996 Mar 27;275(12):913-8.

PMID:
8598618
11.

Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence.

Buist DS, Walker R, Bowles EJ, Carney PA, Taplin SH, Onega T, Kerlikowske K, Clinton W, Miglioretti DL.

Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):720-7. doi: 10.1158/1055-9965.EPI-11-1115. Epub 2012 Feb 1.

12.

Hormone therapy use and breast cancer incidence by histological subtypes in Sweden and Norway.

Suhrke P, Mæhlen J, Zahl PH.

Breast J. 2012 Nov-Dec;18(6):549-56. doi: 10.1111/tbj.12001. Epub 2012 Sep 25.

PMID:
23002918
13.

Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.

Miglioretti DL, Zhu W, Kerlikowske K, Sprague BL, Onega T, Buist DS, Henderson LM, Smith RA; Breast Cancer Surveillance Consortium.

JAMA Oncol. 2015 Nov;1(8):1069-77. doi: 10.1001/jamaoncol.2015.3084.

14.
15.

The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999-2004.

Eheman CR, Shaw KM, Ryerson AB, Miller JW, Ajani UA, White MC.

Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1763-9. doi: 10.1158/1055-9965.EPI-08-1082. Epub 2009 May 19.

16.

Trends of in situ carcinoma of the breast in Vaud, Switzerland.

Levi F, Te VC, Randimbison L, La Vecchia C.

Eur J Cancer. 1997 May;33(6):903-6.

PMID:
9291813
17.

Trends in incidence rates of invasive lobular and ductal breast carcinoma.

Li CI, Anderson BO, Daling JR, Moe RE.

JAMA. 2003 Mar 19;289(11):1421-4.

PMID:
12636465
18.

Overdiagnosis of breast cancer after 14 years of mammography screening.

Zahl PH, Mæhlen J.

Tidsskr Nor Laegeforen. 2012 Feb 21;132(4):414-7. doi: 10.4045/tidsskr.11.0195. English, Norwegian.

20.

Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.

Coldman A, Phillips N.

CMAJ. 2013 Jul 9;185(10):E492-8. doi: 10.1503/cmaj.121791. Epub 2013 Jun 10.

Supplemental Content

Support Center